16. Continuous EEG Monitoring & Nonconvulsive Seizures

Quick Recap

Neurology System, new protocol. Companion to Status Epilepticus (Neurology System), which addresses convulsive status epilepticus management; this protocol addresses the specific challenge of nonconvulsive seizures and nonconvulsive status epilepticus (NCSE) — a diagnosis that, by definition, produces no visible convulsive activity, making continuous EEG monitoring the only reliable detection tool.

1. Definition

Nonconvulsive status epilepticus (NCSE): seizure activity on EEG without the overt convulsive movements of classic generalized tonic-clonic status epilepticus — an important and often unrecognized cause of impaired consciousness in critically ill patients. Reported NCSE frequency in the ICU ranges widely, from 8% to 48% depending on the population studied and diagnostic criteria applied — this wide range itself reflects genuine diagnostic and definitional heterogeneity in the field, not simply different patient populations.

A striking, defining statistic: approximately 90% of ictal (seizure) EEG patterns lack any overt clinical sign — justifying the terms "nonconvulsive" or "subclinical" and explaining why continuous EEG (cEEG), not clinical observation, is the only reliable detection method. Conversely, and equally important to hold in mind: approximately 75% of abnormal movements observed in the ICU are NOT actually seizure-related, stemming from other causes entirely — a genuine bidirectional risk (missing true NCSE from lack of overt signs, and over-attributing unrelated movements to seizure activity) that cEEG interpretation must navigate carefully in both directions.

2. Who to Monitor — Indications for cEEG

cEEG is recommended to identify nonconvulsive seizures/NCSE in critically ill patients with altered mental status when there is: a prior history of epilepsy, unstable level of consciousness, acute brain injury, or recent convulsive status epilepticus. Post-cardiac-arrest patients represent a particularly high-risk population: NCSE has been reported in up to 34% of post-anoxic patients — reinforcing the routine use of cEEG in this population specifically (cross-reference Post-Cardiac Arrest Syndrome, Neurology System, which already establishes EEG as part of the neuroprognostication framework in this population).

A genuinely honest acknowledgment from the guideline literature itself: continuous EEG monitoring is "strongly recommended by guidelines for diagnosing and managing status epilepticus, although the supporting evidence is of low quality" — this protocol treats this explicitly, consistent with this library's broader practice of distinguishing strong guideline language from the actual underlying evidence certainty.

3. A Genuinely Unresolved Controversy — Does NCSE Itself Cause Harm, or Just Mark How Sick the Brain Already Is?

This is a real, actively debated question in the literature, not a settled matter: some studies report NCSE carries high morbidity and mortality requiring aggressive treatment, while others describe it as a comparatively benign finding not requiring aggressive intervention — a genuine split in how the field interprets the same underlying phenomenon.

• One study found NCSE associated with meaningfully increased mortality (31% vs. 14% in non-NCSE patients), and EEG monitoring led to a change in antiseizure drug therapy in 39% of cases — supporting the "NCSE matters, treat it" position
• A separate study specifically in critically ill cancer patients found nonconvulsive seizures did NOT necessarily portend a poor prognosis — a direct, titled challenge to the assumption that detecting NCSE always signals a worse trajectory requiring maximal intervention
• A dedicated Turkish cohort (200 NCSE patients) found mortality strongly tied to etiology (p<0.001) — supporting the interpretation that the underlying cause driving the NCSE, not the NCSE electrographic pattern itself, may be the primary determinant of outcome in many cases, rather than the seizure activity being independently, directly harmful across all contexts

Practical synthesis of this genuine controversy: this protocol does not claim NCSE detection should always trigger maximally aggressive antiseizure therapy regardless of context — the underlying etiology and overall clinical trajectory should inform how aggressively NCSE itself is treated, rather than treating every EEG-detected seizure pattern as an equally urgent, independently life-threatening finding demanding the same intensity of intervention in every patient.

4. The Ictal-Interictal Continuum — A Genuine Interpretive Challenge

Many EEG patterns in critically ill patients fall along an "ictal-interictal continuum" — periodic or rhythmic discharges that are neither clearly ictal (seizure) nor clearly interictal (background abnormality), creating genuine diagnostic ambiguity even for experienced EEG readers. Current diagnostic criteria (e.g., the Salzburg Consensus Criteria) explicitly encourage a treatment trial when the EEG pattern is indeterminate — a pragmatic acknowledgment that this ambiguity is common enough that empirical antiseizure trial-and-response, rather than waiting for EEG certainty, is a reasonable clinical strategy in genuinely uncertain cases.

5. Practical Implementation — What Actually Improves Real Outcomes

A 2024 Swiss single-center before-after study examined the effect of establishing a dedicated ICU-EEG unit (allowing cEEG with near-real-time review and multidisciplinary collaboration, rather than continuous recording with only variable, delayed intermittent review) on status epilepticus outcomes — evaluating return to premorbid neurologic function, ICU mortality, and SE duration as primary outcomes. This reflects a genuinely important practical point: the value of cEEG monitoring depends heavily on how quickly the recorded data is actually reviewed and acted upon — continuous recording sitting unreviewed for hours provides little real-time clinical benefit compared to a system with rapid, structured review built in.

Emerging tools: point-of-care EEG (POC-EEG) systems and AI-assisted EEG interpretation are increasingly used to speed up and simplify diagnostics, particularly relevant where full cEEG infrastructure/expertise isn't continuously available — cross-reference the Artificial Intelligence in Critical Care protocol (ICU Leadership section) for the general framework of evaluating any such tool (external validation, prospective outcome evidence, bias assessment) before trusting it clinically.

6. Severity Scoring

The Salzburg NCSE criteria (SACE score) and other severity scores incorporating systemic illness (not just EEG findings alone) have been developed to better predict outcome — reflecting the growing recognition (Section 3) that overall clinical/systemic context, not the EEG pattern in isolation, meaningfully shapes prognosis.

7. Practical Synthesis

1. Maintain a high index of suspicion and low threshold for cEEG in any critically ill patient with unexplained altered mental status, particularly with prior epilepsy, acute brain injury, or post-cardiac-arrest status
2. Remember the bidirectional risk: most seizures show no overt signs (screen actively), but most observed abnormal movements are NOT seizures either (don't over-attribute)
3. Don't assume every NCSE finding demands maximal, uniformly aggressive treatment — weigh the underlying etiology and overall trajectory, given the genuine controversy over whether NCSE is independently harmful or largely a severity marker
4. Use empirical treatment trials for ictal-interictal-continuum patterns where EEG interpretation alone remains genuinely ambiguous
5. Invest in rapid EEG review infrastructure, not just recording capacity — the 2024 dedicated-unit study suggests review speed, not just monitoring duration, drives real outcome improvement

8. Consultation Matrix

9. Documentation & Medicolegal Checklist

• Indication for cEEG initiation documented
• EEG findings and their classification (clear ictal, clear interictal, or ictal-interictal-continuum) documented
• Rationale for treatment intensity, particularly if withholding maximal antiseizure therapy despite an NCSE finding, documented

10. Key Guidelines

• Salzburg Consensus Criteria for NCSE diagnosis
• Multiple critical care/neurocritical care society guidelines recommend cEEG for this indication, while explicitly noting the underlying evidence quality is low

11. Landmark Evidence

12. Controversies

• Whether NCSE is independently harmful or primarily a marker of underlying illness severity is a genuine, actively unresolved question this protocol treats honestly — the literature contains directly conflicting framings (high morbidity/mortality requiring aggressive treatment vs. a comparatively benign finding), and this protocol does not resolve this in favor of either extreme, instead recommending etiology- and context-informed treatment intensity.
• The ictal-interictal continuum represents genuine, persistent diagnostic ambiguity even among experienced EEG readers — the field's pragmatic response (encouraging empirical treatment trials for indeterminate patterns) is itself an acknowledgment that EEG interpretation alone cannot always resolve the question, not a fully satisfying diagnostic solution.
• Guideline-level "strong recommendation" for cEEG coexists with explicitly "low quality" underlying evidence — this protocol treats this discrepancy as worth naming directly rather than assuming strong guideline language implies strong evidentiary support.

13. References

1. EEG criteria for diagnosing nonconvulsive status epilepticus in comatose patients — An unsolved puzzle: A narrative review. 2023.
2. ICU-Electroencephalogram Unit Improves Outcome in Status Epilepticus. Crit Care Med. 2024.
3. Continuous Electroencephalogram Monitoring in the Intensive Care Unit. 2024-2025.
4. Etiology and Mortality of Nonconvulsive Status Epilepticus. 2025.
5. Non-convulsive seizures in the encephalopathic critically ill cancer patient does not necessarily portend a poor prognosis.
6. Diagnosis, treatment, and outcome prediction of non-convulsive status epilepticus in unconscious patients in intensive care units. 2025.
7. Seizures, Status Epilepticus, and Continuous EEG in the Intensive Care Unit. Continuum (Minneap Minn). 2021.
8. Continuous EEG in ICU: Not a Luxury After All. 2021.
9. Rubinos C, Reynolds AS, Claassen J. The ictal-interictal continuum: to treat or not to treat (and how)? Neurocrit Care. 2018;29(1):3-8.
10. Misirocchi F, Zilioli A, Mannini E, et al. Prognostic value of Salzburg nonconvulsive status epilepticus criteria: The SACE score. Epilepsia. 2024;65:138-147.

See also: Status Epilepticus (Neurology System) for convulsive status epilepticus management; Post-Cardiac Arrest Syndrome (Neurology System) for the high-risk post-anoxic population and its neuroprognostication framework; Artificial Intelligence in Critical Care (ICU Leadership section) for the general framework of evaluating AI-assisted EEG interpretation tools; Diagnostic Error & Cognitive Bias in Critical Care (ICU Leadership section) for the broader caution against over- or under-attributing observed clinical signs to a single suspected cause.